Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Judge

Showing results (211-220 of 260) with videos related to

Pageof 26
Sort By:
Journal of the American College of Cardiology|May 21, 2025
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid CardiomyopathyMathew S Maurer, Daniel P Judge, Julian D Gillmore, et al.
JAMA Cardiology|January 19, 2017
Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyThomas P Mast, Cynthia A James, Hugh Calkins, et al.
Future Cardiology|December 12, 2025
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
European Journal of Heart Failure|March 1, 2022
The response to cardiac resynchronization therapy in LMNA cardiomyopathyKiran Sidhu, Anna Isotta Castrini, Victoria Parikh, et al.
JACC. Basic to Translational Science|July 31, 2025
Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortNatalie Telis, Hang Dai, Ashley Waring, et al.
Journal of Cardiac Failure|June 10, 2026
Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CMBrett W Sperry, Ahmad Masri, Kevin M Alexander, et al.
Science Translational Medicine|February 18, 2021
Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathyStephen P Chelko, Gizem Keceli, Andrea Carpi, et al.
Circulation|May 6, 2015
Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular DystrophyElizabeth M McNally, Jonathan R Kaltman, D Woodrow Benson, et al.
Nature Genetics|February 26, 2005
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2Bart L Loeys, Junji Chen, Enid R Neptune, et al.
Circulation. Heart Failure|May 20, 2025
Antecedent Flu-Like Illness and Onset of Idiopathic Dilated Cardiomyopathy: The DCM Precision Medicine StudyHanyu Ni, Jinwen Cao, Daniel D Kinnamon, et al.
Pageof 26

Showing results (211-220 of 260) with videos related to

Sort By:
Pageof 26
Journal of the American College of Cardiology|May 21, 2025
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid CardiomyopathyMathew S Maurer, Daniel P Judge, Julian D Gillmore, et al.
JAMA Cardiology|January 19, 2017
Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyThomas P Mast, Cynthia A James, Hugh Calkins, et al.
Future Cardiology|December 12, 2025
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
European Journal of Heart Failure|March 1, 2022
The response to cardiac resynchronization therapy in LMNA cardiomyopathyKiran Sidhu, Anna Isotta Castrini, Victoria Parikh, et al.
JACC. Basic to Translational Science|July 31, 2025
Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortNatalie Telis, Hang Dai, Ashley Waring, et al.
Journal of Cardiac Failure|June 10, 2026
Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CMBrett W Sperry, Ahmad Masri, Kevin M Alexander, et al.
Science Translational Medicine|February 18, 2021
Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathyStephen P Chelko, Gizem Keceli, Andrea Carpi, et al.
Circulation|May 6, 2015
Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular DystrophyElizabeth M McNally, Jonathan R Kaltman, D Woodrow Benson, et al.
Nature Genetics|February 26, 2005
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2Bart L Loeys, Junji Chen, Enid R Neptune, et al.
Circulation. Heart Failure|May 20, 2025
Antecedent Flu-Like Illness and Onset of Idiopathic Dilated Cardiomyopathy: The DCM Precision Medicine StudyHanyu Ni, Jinwen Cao, Daniel D Kinnamon, et al.
Pageof 26